IGM Biosciences (IGMS) Competitors $1.18 -0.06 (-4.84%) Closing price 04:00 PM EasternExtended Trading$1.18 0.00 (-0.42%) As of 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IGMS vs. ACB, AQST, CMPX, DBVT, CRVS, IMMP, RNAC, AURA, CGC, and TSVTShould you be buying IGM Biosciences stock or one of its competitors? The main competitors of IGM Biosciences include Aurora Cannabis (ACB), Aquestive Therapeutics (AQST), Compass Therapeutics (CMPX), DBV Technologies (DBVT), Corvus Pharmaceuticals (CRVS), Immutep (IMMP), Cartesian Therapeutics (RNAC), Aura Biosciences (AURA), Canopy Growth (CGC), and 2seventy bio (TSVT). These companies are all part of the "pharmaceutical products" industry. IGM Biosciences vs. Aurora Cannabis Aquestive Therapeutics Compass Therapeutics DBV Technologies Corvus Pharmaceuticals Immutep Cartesian Therapeutics Aura Biosciences Canopy Growth 2seventy bio IGM Biosciences (NASDAQ:IGMS) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends. Do insiders & institutionals believe in IGMS or ACB? 42.8% of IGM Biosciences shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 57.0% of IGM Biosciences shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer IGMS or ACB? Aurora Cannabis received 312 more outperform votes than IGM Biosciences when rated by MarketBeat users. Likewise, 59.63% of users gave Aurora Cannabis an outperform vote while only 47.68% of users gave IGM Biosciences an outperform vote. CompanyUnderperformOutperformIGM BiosciencesOutperform Votes7247.68% Underperform Votes7952.32% Aurora CannabisOutperform Votes38459.63% Underperform Votes26040.37% Does the media prefer IGMS or ACB? In the previous week, IGM Biosciences and IGM Biosciences both had 1 articles in the media. IGM Biosciences' average media sentiment score of 1.79 beat Aurora Cannabis' score of 0.81 indicating that IGM Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IGM Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Aurora Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate IGMS or ACB? IGM Biosciences currently has a consensus price target of $5.50, suggesting a potential upside of 366.10%. Given IGM Biosciences' higher probable upside, equities analysts plainly believe IGM Biosciences is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IGM Biosciences 1 Sell rating(s) 9 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.90Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 Which has higher earnings and valuation, IGMS or ACB? Aurora Cannabis has higher revenue and earnings than IGM Biosciences. IGM Biosciences is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIGM Biosciences$2.68M26.33-$246.42M-$3.27-0.36Aurora Cannabis$320.81M0.91-$48.62M$0.05104.40 Is IGMS or ACB more profitable? Aurora Cannabis has a net margin of 0.42% compared to IGM Biosciences' net margin of -7,534.03%. Aurora Cannabis' return on equity of 0.59% beat IGM Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets IGM Biosciences-7,534.03% -155.42% -61.04% Aurora Cannabis 0.42%0.59%0.42% Which has more volatility & risk, IGMS or ACB? IGM Biosciences has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.94, suggesting that its share price is 94% more volatile than the S&P 500. SummaryAurora Cannabis beats IGM Biosciences on 14 of the 18 factors compared between the two stocks. Get IGM Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IGMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IGMS vs. The Competition Export to ExcelMetricIGM BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$70.53M$6.52B$5.37B$8.38BDividend YieldN/A2.65%5.22%4.11%P/E Ratio-0.328.9226.8419.71Price / Sales26.33253.80392.34117.39Price / CashN/A65.8538.2534.62Price / Book0.346.466.794.50Net Income-$246.42M$143.98M$3.23B$248.18M7 Day Performance3.51%3.04%4.07%1.14%1 Month Performance-7.81%7.44%12.52%15.20%1 Year Performance-85.97%-2.46%16.83%6.56% IGM Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IGMSIGM Biosciences4.2765 of 5 stars$1.18-4.8%$5.50+366.1%-85.2%$70.53M$2.68M-0.32190Positive NewsGap DownACBAurora Cannabis0.6152 of 5 stars$5.06+4.3%N/A-27.8%$284.44M$320.81M101.221,340News CoverageAQSTAquestive Therapeutics1.2992 of 5 stars$2.85+2.2%$10.67+274.3%-25.1%$283.07M$57.56M-6.33160News CoveragePositive NewsAnalyst RevisionGap UpCMPXCompass Therapeutics3.6803 of 5 stars$2.01+10.4%$13.13+553.0%+31.3%$277.95M$850,000.00-5.4320DBVTDBV Technologies2.7863 of 5 stars$10.13+3.1%$15.50+53.0%+52.4%$277.46M$15.73M-2.2580Gap DownCRVSCorvus Pharmaceuticals2.4031 of 5 stars$4.05-8.6%$16.33+303.3%+61.4%$276.08MN/A-4.3530Analyst ForecastHigh Trading VolumeIMMPImmutep1.5354 of 5 stars$1.87+1.1%$8.50+354.5%-35.2%$273.09M$5.14M0.002,021RNACCartesian Therapeutics1.5333 of 5 stars$10.44+5.5%$42.50+307.1%-60.4%$270.78M$38.91M-0.2064News CoverageAnalyst RevisionGap UpAURAAura Biosciences2.4576 of 5 stars$5.35+2.3%$22.75+325.2%-16.5%$268.70MN/A-3.0950Earnings ReportInsider TradeGap UpCGCCanopy Growth1.4028 of 5 stars$1.46+11.5%$2.00+37.0%-82.5%$268.44M$276.75M-0.383,150Trending NewsTSVT2seventy bio1.5274 of 5 stars$5.00+0.2%$4.25-15.0%N/A$266.15M$37.86M-2.69440News Coverage Related Companies and Tools Related Companies ACB Alternatives AQST Alternatives CMPX Alternatives DBVT Alternatives CRVS Alternatives IMMP Alternatives RNAC Alternatives AURA Alternatives CGC Alternatives TSVT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IGMS) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGM Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
